Hepatic veno-occlusive disease in pediatric stem cell recipients: Successful treatment with continuous infusion of prostaglandin E1 and low-dose heparin

Annals of Hematology

Volumn 76, Issue 1, 1998, Pages 37-41

  Schlegel, P G ^a   Haber, H P ^a   Beck, J ^a   Krumpelmann S ^a   Handgretinger, R ^a   Bader, P ^a   Bierings, M ^a   Niethammer, D ^a   Klingebiel, T ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Duplex ultrasound; Hepatic veno occlusive disease; Pediatric; Prostaglandin E1; Treatment; VOD

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; HEPARIN; PROSTAGLANDIN E1;

ALLOGRAFT; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; COLLATERAL CIRCULATION; DISEASE COURSE; DOPPLER ECHOGRAPHY; DRUG INFUSION; HEPATIC VEIN; HISTIOCYTOSIS; HUMAN; HYPOTENSION; INFANT; LIVER VEIN OBSTRUCTION; LUNG FLUID; MAXIMUM PERMISSIBLE DOSE; PORTAL VEIN BLOOD FLOW; PRESCHOOL CHILD; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SYMPTOM; TREATMENT OUTCOME; VEIN BLOOD FLOW; WISKOTT ALDRICH SYNDROME;

ALPROSTADIL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPARIN; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; INFANT;

EID: 0031965306     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050358     Document Type: Article

References (27)

1. Attal M, Huguet F, Rubie H Huguet F, Ruble H, Huynh A, Charlet JP, Payen JL, Voigt JJ, Brousset P, Selves J, Muller C, Pris J, Laurent G (1992) Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective randomized trial. Blood 79:2834-2840
2. Bearman SI (1995) The syndrome of hepatic veno-occlusive disease after bone marrow transplantation. Blood 85:3005-3020
3. 1 for the prevention of hepatic veno-occlusive disease after bone marrow transplantation. Br J Haematol 84:724-730
4. Bearman SI, Lee JL, Barón AE, McDonald GB (1997) Treatment of hepatic veno-occlusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant recipients. Blood 89:1501-1506
5. Blostein MD, Paltiel OB, Tribault A, Rybka WB (1992) A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation. Bone Marrow Transplant 10:439-443
6. Brown BP, Abu-Yousef M, Farner R LaBrecque D, Gingrich R (1990) Doppler sonography: a non-invasive method for the evaluation of hepatic venocclusive disease. AJR 154:721-724
7. Carreras E, Berz H, Vernant JP, et al. on behalf of the Chronic Leukemia Working Party (1996) Incidence of hepatic veno-occlusive disease (VOD) after BMT in Europe: A prospective cohort study of the EBMT. Blood 88 (Suppl. 1):415a
8. Chao NJ, Schlegel PG (1995) Prevention and treatment of graft-versus-host disease. Ann NY Acad Sci 770:130-140
9. Chao NJ, Schmidt GM, Niland JC et al. (1993) Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. N Engl J Med 329:1225-1230
10. Demuynck H, Vandenberghe P, Verhoef GEG, Zachee P, Boogaerts MA (1995) Prevention of veno-occlusive disease (VOD) of the liver after marrow and blood progenitor cell transplantation: A prospective, randomized study of different prophylactic regimens. Blood 86 (Suppl. 1): 620a
11. Dix SP, Wingard JR, Mullins RE et al. (1996) Association of busulfan area under the curve with veno-occlusive disease following BMT. Bone Marrow Transplant 17:225-230
12. 1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic hone marrow transplantation. Br J Haematol 74:277-281
13. Graphakos S, Goussetis E, Peristeri J, Kitra V, Papadakis V, Aroni S (1996) High-dose, continuous r-TPA infusion for treatment of VOD. Bone Marrow Transplant 18:1026-1028
14. Grochow LB, Piantadosi S, Santos G et al. (1992) Busulfan dose adjustment decreases the risk of hepatic veno-occlusive disease in patients undergoing bone marrow transplantation. Proc AACR 33:1197
15. + progenitors. Blood 88[Suppl 1]:253a
16. Hommeyer SC, Teefey SA, Jacobson AF, Higano CS, Bianco JA, Colacurcio CJ, McDonald GB (1992) Veno-occlusive disease of the liver: prospective study of US evaluation. Radiology 184:683-686
17. 1. Bone Marrow Transplant 7[Suppl 2]:53
18. Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG, Vogelsang BG, Sensenbrenner LL, Santos GW, Saral R (1987) Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 44:778-783
19. Kusnierz-Glaz CR, Schlegel PG, Wong RM et al. (1997) The influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies. J Clin Oncol 15:18-25
20. Leahey AM, Bunin NJ (1996) Recombinant human tissue plasminogen activator for the treatment of severe hepatic veno-occlusive disease in pediatric bone marrow transplant recipients. Bone Marrow Transplant 17:1101-1104
21. McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, Hardin BJ, Shulman HM, Clift RA (1193) Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 335 patients. Ann Intern Med 118:255-267
22. Otheo de Tejada E, Maldonado M, Camarero C, Munoz A (1994) Fatal hemorrhage after recombinant tissue plasminogen activator therapy for hepatic veno-occlusive disease after allogeneic BMT in a pediatric patient. Bone Marrow Transplant 14:176-177
23. Patton DF, Harper JL, Wooldridge TN , Gordon BG, Coccia P, Haire WD (1996) Treatment of veno-occlusive disease of the liver with bolus tissue plasminogen activator and continuous infusion antithrombin III concentrate. Bone Marrow Transplant 17:443-447
24. Richardson P, Krishnan A, Wheeler C, Ayash L, Hoppensteadt D, Fareed J, Schnipper L, Kufe D, Frei E III, Elias A (1995) The use of defibrotide (DF) in BMT-associated venoocclusive disease (VOD). Blood 86[Suppl 1]:221a
25. Ringden O, Wennberg L, Ericzon BG, Kallman R, Aström M, Duraj F, Söderdahl G, Tyden G, Groth CG (1992) Altepase for hepatic veno-occlusive disease after bone marrow transplantation. Lancet 340:546-547
26. Rozman C, Carreras E., Qian C et al. (1996) Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia. Bone Marrow Transplant 17:75-80
27. Schuler U, Subat S, Schmidt H, Schneider A, Ehninger G (1996) Evaluation of procollagen-III peptide as a marker for veno-occlusive disease after bone marrow transplantation. Ann Hematol 73:25-28